Lessons from cost-effectiveness of HIV vaccines for COVID vaccines

Will HIV vaccines compete with existing HIV prevention strategies? Who is doing COVID vaccine cost-effectiveness analysis? Fred Hutch Science Spotlight translated the math in our peer-reviewed paper published in the Journal of the International AIDS Society to explain the economic tradeoffs of delivering an HIV vaccine in Seattle in the future. Our prior review of … Continue reading Lessons from cost-effectiveness of HIV vaccines for COVID vaccines

Population targets and vaccine durability in South Africa

New paper in Vaccine shows staggered age targeting and the durability of protection will be key to strategic and efficient vaccination in South Africa. When an HIV vaccine is ready to launch in South Africa, an efficient implementation strategy needs to be ready. I worked with 3 women scientists in South Africa, 3 academic men … Continue reading Population targets and vaccine durability in South Africa

Doctoral Dissertation Defense

An Invitation Please join us at my doctoral dissertation defense titled “Mathematical Models to Evaluate the Clinical and Economic Impact of Biomedical HIV Prevention Strategies in the United States” at 12:30 pm on Thursday, May 3, 2018 at the Washington Research Foundation (WRF) Data Science Studio on the 6th floor of the Physics/Astronomy Tower at the University of Washington … Continue reading Doctoral Dissertation Defense